Business Context and Reporting Period
Company: Teradyne, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 2, 2006
Business Overview: Teradyne is a leading supplier of automatic test equipment, operating through three reportable segments: Semiconductor Test Systems, Assembly Test Systems, and Other Test Systems (combining Diagnostic Solutions and Broadband Test Systems). The company recently sold its Connection Systems segment in November 2005, which is now reported as discontinued operations.
Key Financial Metrics
| Metric | Q1 2006 | Q1 2005 |
|---|---|---|
| Net Revenues | $362.9 million | $210.4 million |
| Gross Profit | $170.6 million | $77.7 million |
| Gross Margin | 47.0% | 36.9% |
| Operating Income | $47.4 million | ($54.4 million) Loss |
| Net Income (Continuing Ops) | $44.9 million | ($55.5 million) Loss |
| Diluted EPS (Continuing Ops) | $0.23 | ($0.28) |
| Operating Cash Flow | $71.9 million | ($55.5 million) |
| Cash & Marketable Securities | $965.9 million | $554.7 million |
| Long-Term Debt (Current Portion) | $285.0 million | $300.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 72.5% year-over-year, driven primarily by a 99.1% surge in Semiconductor Test Systems revenue due to capacity expansion in the system-on-a-chip (SOC) market and strong demand for FLEX and J750 test systems.
- Profitability Turnaround: The company shifted from a net loss of $52.6 million in Q1 2005 to a net income of $44.9 million in Q1 2006. This was aided by higher volume, improved product mix, and reduced operating expenses.
- Expense Management: Engineering and development expenses decreased by $9.2 million (14.9%) due to headcount reductions and lower prototype costs. Selling and administrative expenses increased by $7.9 million, largely due to higher variable compensation tied to improved performance.
- Inventory Provisions: The company recorded an $8.3 million provision for excess and obsolete inventory in Q1 2006, compared to $2.1 million in Q1 2005. Despite this, gross margins expanded significantly.
- Debt Reduction: Teradyne repurchased $15 million of its 3.75% Convertible Senior Notes, reducing the outstanding balance to $285 million.
Guidance, Outlook, and Risks
- Backlog: Total backlog of unfilled orders increased to $423.0 million as of April 2, 2006, up from $357.7 million in the prior year, with Semiconductor Test Systems accounting for the majority ($304.3 million).
- Accounting Changes: Effective January 1, 2006, the company adopted SFAS 123R (Share-Based Payment), recognizing stock-based compensation expense of $6.1 million for the quarter. This reduced net income by approximately $0.03 per share.
- Liquidity: Management believes the cash and marketable securities balance of $965.9 million is sufficient to meet working capital and expenditure needs for at least the next 12 months.
- Risks: Key risks include the cyclical nature of the electronics market, intense competition, reliance on key customers, potential supply chain disruptions, and ongoing legal proceedings regarding prior acquisitions (Herco Technology and Perception Laminates) and environmental liabilities.
- Subsequent Event: In April 2006, the company sold three buildings for net proceeds of approximately $36.4 million.
Investor Verification Checklist
- Sustainability of Semiconductor Growth: Verify if the 99% revenue increase in Semiconductor Test Systems is sustainable or driven by one-time capacity expansion orders.
- Inventory Health: Monitor future quarters for continued inventory write-downs, given the $8.3 million provision and $159.2 million in existing reserves.
- Restructuring Accruals: Track the payout of the $11.9 million remaining restructuring accrual (facility and severance) and the realization of expected sublease income.
- Convertible Notes: Assess the impact of the remaining $285 million in convertible notes due in 2006 on future liquidity and potential dilution.
- Legal Contingencies: Review the status of the pending appeal regarding the Herco/Perception acquisition and the environmental PRP designation in Los Angeles.